Currently, gene therapy in LHON aims to deliver the un-mutated MT-ND4 gene into RGC nuclei with the goal of producing functioning proteins/complex I subunits that can be embedded into the mitochondrial respiratory chain. The gene discussed is MT-ND4; the disease is Leber hereditary optic neuropathy.